Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mark A. Marzinke"'
Autor:
Mark A. Marzinke, Jining Zhang, Rob Fanter, Priya Srinivasan, James M. Smith, Flora Yang, Craig W. Hendrix, Manjula Gunawardana, Irina Butkyavichene, Marc M. Baum, Shanon Ellis, John A. Moss, Christine S. Miller, Debbie Sanchez, Amita Kapoor
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 10, p e0185946 (2017)
PLoS ONE, Vol 12, Iss 10, p e0185946 (2017)
Globally, women bear an uneven burden for sexual HIV acquisition. Results from two clinical trials evaluating intravaginal rings (IVRs) delivering the antiretroviral agent dapivirine have shown that protection from HIV infection can be achieved with
Autor:
Kenneth K. Mugwanya, Grace John-Stewart, Connie Celum, Craig W. Hendrix, Kenneth Ngure, Timothy R Muwonge, Elly Katabira, Nelly Mugo, Jared M. Baeten, Mark A. Marzinke, Andy Stergachis, Gabriel Muthuri, Nulu Semiyaga
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 13, Iss 9, p e1002132 (2016)
PLoS Medicine, Vol 13, Iss 9, p e1002132 (2016)
Background As pre-exposure prophylaxis (PrEP) becomes more widely used in heterosexual populations, an important consideration is its safety in infants who are breastfed by women taking PrEP. We investigated whether tenofovir and emtricitabine are ex
Autor:
Nicola Richardson-Harman, Christine K. Mauck, Jarret Engstrom, Khaja K. Rehman, Lisa C. Rohan, Kaleab Z. Abebe, Craig W. Hendrix, Hiwot Hiruy, Elena Khanukhova, Alexyi Nikiforov, Ian McGowan, Peter A. Anton, Cindy Jacobson, Charlene S. Dezzutti, Ross D. Cranston, Kathryn Duffill, Mark A. Marzinke, Julie Elliott, Hans M. L. Spiegel, Aaron Siegel
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 5, p e0125363 (2015)
PLoS ONE, Vol 10, Iss 5, p e0125363 (2015)
Objectives The CHARM-01 study characterized the safety, acceptability, pharmacokinetics (PK), and pharmacodynamics (PD) of three tenofovir (TFV) gels for rectal application. The vaginal formulation (VF) gel was previously used in the CAPRISA 004 and